Updated on 2023/11/30

写真a

 
SAKURAI Toshihiko
 
Title
Assistant Professor(Moving Out or Retirement)
 

Papers

  • Effect of general self-efficacy on promoting health-related quality of life during recovery from radical prostatectomy: a 1-year prospective study., Internatinal Journal of Clinical Oncology, 2020.12

    Kawaguchi K, Kawazoe H, Sakurai T, Nishida H, Kanno H, Naito S, Kato T, Konta T, Tsuchiya N, Sato W.: Effect of general self-efficacy on promoting health-related quality of life during recovery from r...

    Multiple Authorship (Only Japanese)

  • Differential prognostic factors in low- and high-burden de novo metastatic hormone-sensitive prostate cancer patients., Cancer Science, 2020.11

    Shiota M, Terada N, Saito T, Yokomizo A, Kohei N, Goto T, Kawamura S, Hashimoto Y, Takahashi A, Kimura T, Tabata KI, Tomida R, Hashimoto K, Sakurai T, Shimazui T, Sakamoto S, Kamiyama M, Tanaka N, Mit...

    Multiple Authorship (Only Japanese)

  • Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration-sensitive prostate cancer: A multicenter retrospective study., Internatinal Journal of Urology, 2020.07

    Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Hamano I, Okamoto T, Mitsuzuka K, Ito A, Tsuchiya N, Arai Y, Habuchi T, Ohyam...

    Multiple Authorship (Only Japanese)

  • New prognostic model for synchronous metastatic renal cell carcinoma., Internatinal Journal of Urology, 2020.05

    Naito S, Kato T, Ichiyanagi O, Narisawa T, Kurokawa M, Yagi M, Ushijima M, Ozawa M, Kanno H, Kurota Y, Fukuhara H, Kuboki Y, Yamagishi A, Sakurai T, Nishida H, Yamanobe T, Tsuchiya N

    Multiple Authorship (Only Japanese)

  • Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan. , Internatinal Journal of Clinical Oncology, 2020.05

    Narita S, Hatakeyama S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Koizumi A, Mitsuzuka K, Tochigi T, Tsuchiya N, Ohyama C, Arai Y, Nomura K, Ha...

    Multiple Authorship (Only Japanese)

  • The Effect of Treatment Sequence on Overall Survival for Men With Metastatic Castration-resistant Prostate Cancer: A Multicenter Retrospective Study. Clin Genitourin Cancer., Clinical Genitourinariy Cancer, 2020.04

    Okita K, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Mitsuzuka K, Ito A, Tsuchiya N, Arai Y, Habuchi T, Ohyama C

    Multiple Authorship (Only Japanese)

  • Clinical Characterization of Low Prostate-specific Antigen on Prognosis in Patients With Metastatic Castration-naive Prostate Cancer. Clin Genitourin Cancer., Clinical Genitourinariy Cancer, 2019.12

    Kodama H, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Narita T, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Arai Y, Habuchi T, Oh...

    Multiple Authorship (Only Japanese)

  • GPI-80 as a Useful Index for Myeloid Cell Heterogeneity and a Potential Prognostic Biomarker for Metastatic Renal Cell Carcinoma., Tohoku J Exp Med, 2019.11

    Kato T, Takeda Y, Ito H, Kurota Y, Yamagishi A, Sakurai T, Naito S, Araki A, Nara H, Asao H, Tsuchiya N

    Multiple Authorship (Only Japanese)

  • Effect of third- and fourth-line systemic therapies for metastatic renal cell carcinoma., Science Report, 2019.10

    Naito S, Ichiyanagi O, Kato T, Kanno H, Narisawa T, Kurokawa M, Ushijima M, Ozawa M, Yagi M, Kurota Y, Fukuhara H, Yamagishi A, Sakurai T, Nishida H, Kawazoe H, Yamanobe T, Tsuchiya N

    Multiple Authorship (Only Japanese)

  • Editorial Comment to Progression of hypertension after partial nephrectomy in patients with renal tumors: A preliminary report., International Journal of Urology, 2015.08

    Toshihiko Sakurai

    Single Author

  • 3. The enhancer of zeste homolog 2 (EZH2), a potential therapeutic target, is regulated by miR-101 in renal cancer cells., Biochemical and Biophysical Research Communications, 2012.06

    Sakurai T, Bilim VN, Ugolkov AV, Yuuki K, Tsukigi M, Motoyama T, Tomita Y.

    Multiple Authorship (Including Foreigners)

display all >>

Grant-in-Aid for Scientific Research

  • Grant-in-Aid for Scientific Research(C),2022.04 - 2023.03

  • Grant-in-Aid for Scientific Research(C),2019.04 - 2022.03